Guideline No. 393-Diabetes in Pregnancy

Overview

Journal J Obstet Gynaecol Can

Publisher Elsevier

Specialty Gynecology & Obstetrics

Date 2019 Dec 2

PMID 31785800

Citations 38

Authors

Howard Berger

Robert Gagnon

Mathew Sermer

Affiliations

Soon will be listed here.

Abstract

Objectives: This guideline reviews the evidence relating to the diagnosis and obstetrical management of diabetes in pregnancy.

Outcomes: The outcomes evaluated were short and long-term maternal outcomes including pre-eclampsia, Caesarean section, future diabetes and other cardiovascular complications; and fetal outcomes including congenital anomalies, stillbirth, macrosomia, birth trauma, hypoglycemia and long-term effects.

Evidence: Published literature was retrieved through searches of PubMed and The Cochrane Library using appropriate controlled vocabulary (MeSH terms "diabetes" and "pregnancy"). Where appropriate, results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies. There were no date limits but results were limited to English or French language materials.

Values: The quality of evidence was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care.

Summary Statements: RECOMMENDATIONS.

Citing Articles

The relationship between timing of screening for gestational diabetes mellitus and maternal and fetal outcomes: A retrospective cohort study linking primary care electronic and hospital administrative data.

Piccinini-Vallis H, Grandy M, Bussey L, Coolen J, Sabri S Obes Pillars. 2025; 13:100159.

PMID: 39896975 PMC: 11786742. DOI: 10.1016/j.obpill.2025.100159.

Women's perspectives to improve prenatal care for gestational diabetes: A systematic review and meta-aggregation of qualitative studies.

Feng Y, Deng Z, Sivak A, Yeung R, Nagpal T Acta Obstet Gynecol Scand. 2024; 104(2):267-287.

PMID: 39656503 PMC: 11782075. DOI: 10.1111/aogs.14973.

Adverse pregnancy outcomes and multiple cancers risk in both mother and offspring: an umbrella review of systematic reviews with meta-analyses of observational studies.

Liu N, Bao R, Chang Y, Liu F, Wu L, Wang J BMC Med. 2024; 22(1):454.

PMID: 39394137 PMC: 11470735. DOI: 10.1186/s12916-024-03680-w.

Gestational Diabetes: An Update 60 Years After O'Sullivan and Mahan.

McIntyre H, Kampmann U, Clausen T, Laurie J, Ma R J Clin Endocrinol Metab. 2024; 110(1):e19-e31.

PMID: 39389786 PMC: 11651698. DOI: 10.1210/clinem/dgae709.

Glycated CD59 is a potential biomarker for gestational diabetes mellitus.

Wang W, Xu C, Lu X, Cao W, Zuo T, Zhang Y Front Endocrinol (Lausanne). 2024; 15:1374253.

PMID: 39351537 PMC: 11439654. DOI: 10.3389/fendo.2024.1374253.